If you liked this article you might like

Here Are Some Small-Cap Pharma M&A Targets After Relypsa Deal
Investors Scour Big Pharma M&A Scene for Next Big Takeover
Shire Could Divest ADHD Treatment, Other Assets, for More Upside Post-Baxalta
Cramer: 11 Reasons Why the Market Turned